CO2 Solution Obtains Exclusive Global Rights to Leading Enzyme Delivery Technology
TSX-V: CST Outstanding shares: 60,261,136
Agreement with CLEA Technologies B.V. provides CO2 Solution with advanced technology for industrial application of enzyme for carbon capture
It is expected that the CLEA technology will provide for a robust method of using the carbonic anhydrase in CO2 Solution’s carbon capture process, and builds upon the proven commercial application of the CLEA technology for the fine chemicals and pharmaceutical industry. The CLEA technology provides an alternative to using soluble enzyme and may further improve overall economics of the process. Furthermore, the CLEA manufacturing process is proven, and relatively simple, allowing for expected ease of scale-up.
The Agreement is another milestone towards execution of the Company’s three-pronged technology development and optimization strategy which includes the enzyme, immobilization (enzyme delivery) and process. With the Agreement providing advanced immobilization technology, it builds on recent agreements with other specialist technology leaders, including Codexis, Inc., for robust, low cost enzymes, and Procede Group B.V. for process optimization. Additionally under the Agreement, the parties will also explore other promising enzyme immobilization and delivery technologies in which CLEATECH has significant expertise.
Commenting on the Agreement,
About CO2 Solution
Based in Quebec City, CO2 Solution Inc. has developed a proprietary bio-technological platform for the efficient capture of carbon dioxide (CO2), the most important greenhouse gas (GHG), from power plants and other large stationary sources of emissions. The Company’s technology platform exploits the natural power of a bio-catalyst (enzyme), carbonic anhydrase, which functions within humans and other mammals to manage CO2 during respiration. CO2 Solution has successfully adapted the enzyme to function within an industrial environment, and thus has taken advantage of a biomimetic approach to CO2 capture based on millions of years of evolution. The Company is commercializing its technology for coal fired power generation, the oil sands and other CO2-intensive industries where a low-cost capture solution is key to addressing climate change in a cost effective manner.
CO2 Solution’s technology platform is protected by several North American and European patents, including the use of carbonic anhydrase for CO2 capture and release in a packed column system. News releases and additional information can be found at www.co2solution.com
Forward-looking Statements: Certain statements in this news release may be forward-looking. These statements relate to future events or CO2 Solution’s future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operation described herein. CO2 Solution undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE CO2 SOLUTION INC.